| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |